Skip to main content
. 2004 Jul-Aug;15(4):213–220. doi: 10.1155/2004/383461

TABLE 4.

Sensitivity analysis results

Linezolid group* Vancomycin IV Group*
Sensititvity analysis Hospital cost Nonhospital cost Total cost Hospital cost Nonhospital cost Total cost
Conservative switch therapy eligibility for linezolid group $7,694 $442 $8,136 $7,846 $597 $8,444
No early discharge eligibility for linezolid patients $8,462 $316 $8,778 $7,846 $597 $8,444
Increased hospitalization cost ($1,002/day) $17,326 $442 $17,768 $18,324 $597 $18,921
Decreased hospital anti-infective costs (-20%) $7,505 $442 $7,947 $7,744 $597 $8,342
Increased hospital anti-infective costs (20%) $7,882 $442 $8,325 $7,948 $597 $8,545
*

Costs expressed as cost per patient. IV Intravenous